
Ivazest 7.5mg Tablet
Marketer
Innovative Pharmaceuticals
Salt Composition
Ivabradine (7.5mg)
Overview Ivazest 7.5mg Tablet
Cardiorest 7.5mg tablets treat angina pectoris (chest pain stemming from heart conditions) and long-standing heart failure. It improves cardiac efficiency by reducing heart rate, thus easing chest discomfort and minimizing hospitalizations for heart failure patients. Dosage varies based on the specific condition. As treatment is generally lifelong, cessation requires physician consultation. Consistent daily intake with food is recommended. Overdosage may cause excessive bradycardia, leading to fatigue and shortness of breath; seek immediate medical attention if this occurs. Common side effects include transient visual disturbances, bradycardia, hypertension, atrial fibrillation, vertigo, blurred vision, and electrocardiographic abnormalities. Serious adverse effects like syncope and significant arrhythmias warrant urgent medical care. Refrain from driving until the medication's effects are known. Avoid Cardiorest 7.5mg tablets if you have severe hepatic impairment, resting bradycardia, cardiac arrhythmias, severely low blood pressure, or recently exacerbated heart failure. Interactions exist with certain antihypertensives, antifungals, and antiretrovirals. Contraindicated during pregnancy, attempts at conception, and lactation.
Uses of Ivazest 7.5mg Tablet
Managing angina pectoris and heart failure.
Major Benefits of Ivazest 7.5mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the 7.5mg Ivazest tablet whole; avoid chewing, crushing, or fracturing it. Take it with a meal.
Common Side effects of Ivazest 7.5mg Tablet:
- Slow heart rate
- Luminous phenomena (Enhanced brightness)
- High blood pressure
- Atrial fibrillation
- Dizziness
- Blurred vision
- ECG changes
How to use Ivazest 7.5mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Ivazest 7.5mg Tablet should be administered with a meal.
How Ivazest 7.5mg Tablet works:
Ivazest 7.5mg tablets decrease cardiac rate, thereby diminishing the heart's oxygen demand and improving its overall efficiency.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction between Ivazest 7.5mg Tablet and alcohol is undefined regarding safety. Seek medical advice before combining them.
PregnancyUNSAFE
Using Ivazest 7.5mg tablets during pregnancy poses a substantial risk. Pregnant women should consult their physician before use, as research in both animals and pregnant humans indicates considerable harm to the fetus.
Breast feedingUNSAFE
Breastfeeding mothers should not take Ivazest 7.5mg tablets. Evidence indicates potential infant harm from this medication.
DrivingUNSAFE
Driving ability may be impaired by Ivazest 7.5mg Tablets, which can induce temporary visual disturbances, primarily characterized by phosphenes. The potential for these light flashes should be considered, particularly during nighttime driving.
KidneyCAUTION
Exercise caution when administering Ivazest 7.5mg Tablets to individuals with severely impaired kidney function. Dosage modification may be necessary. A physician's consultation is recommended. Data regarding Ivazest 7.5mg Tablet use in patients with severe renal impairment is limited.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Ivazest 7.5mg tablets, potentially requiring dosage modification. Medical advice is necessary. Ivazest 7.5mg tablets are contraindicated in patients exhibiting severe liver dysfunction.
What if you forget to take Ivazest 7.5mg Tablet :
Omit any missed Ivazest 7.5mg Tablet dose and resume your regular medication regimen. Avoid taking a double dose.
Facts to Know About Ivazest 7.5mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Benzazepine compound |
| Developing Habits | No. |
| Treatment Category | HEART |
| Action Class | Sinoatrial node I<sub>f</sub> sodium channel blockers |
